West Pharmaceutical Services, Inc. (WST) Shares Sold by Northwestern Mutual Investment Management Company LLC

Northwestern Mutual Investment Management Company LLC lessened its position in West Pharmaceutical Services, Inc. (NYSE:WST) by 0.1% in the second quarter, according to its most recent disclosure with the SEC. The firm owned 12,616 shares of the medical instruments supplier’s stock after selling 9 shares during the period. Northwestern Mutual Investment Management Company LLC’s holdings in West Pharmaceutical Services were worth $957,000 as of its most recent filing with the SEC.

Several other large investors also recently made changes to their positions in WST. American Century Companies Inc. lifted its holdings in West Pharmaceutical Services by 0.4% during the second quarter. American Century Companies Inc. now owns 701,364 shares of the medical instruments supplier’s stock worth $66,293,000 after acquiring an additional 2,605 shares during the period. Kayne Anderson Rudnick Investment Management LLC lifted its holdings in West Pharmaceutical Services by 18.3% during the first quarter. Kayne Anderson Rudnick Investment Management LLC now owns 30,960 shares of the medical instruments supplier’s stock worth $2,526,000 after acquiring an additional 4,787 shares during the period. CIBC Asset Management Inc bought a new stake in West Pharmaceutical Services during the second quarter worth $223,000. State Board of Administration of Florida Retirement System lifted its holdings in West Pharmaceutical Services by 16.7% during the second quarter. State Board of Administration of Florida Retirement System now owns 88,252 shares of the medical instruments supplier’s stock worth $8,342,000 after acquiring an additional 12,609 shares during the period. Finally, Prudential Financial Inc. lifted its holdings in West Pharmaceutical Services by 149.6% during the second quarter. Prudential Financial Inc. now owns 400,270 shares of the medical instruments supplier’s stock worth $37,834,000 after acquiring an additional 239,906 shares during the period. 90.57% of the stock is currently owned by institutional investors.

A number of brokerages recently commented on WST. Zacks Investment Research upgraded West Pharmaceutical Services from a “hold” rating to a “strong-buy” rating and set a $114.00 price target on the stock in a report on Friday, June 9th. BidaskClub lowered West Pharmaceutical Services from a “strong-buy” rating to a “buy” rating in a report on Tuesday, June 13th. Finally, Jefferies Group LLC upgraded West Pharmaceutical Services from a “hold” rating to a “buy” rating and boosted their target price for the company from $96.00 to $115.00 in a research note on Friday, September 15th. Two equities research analysts have rated the stock with a sell rating and three have assigned a buy rating to the stock. The company presently has an average rating of “Hold” and an average price target of $98.52.

Shares of West Pharmaceutical Services, Inc. (WST) opened at 95.21 on Friday. The firm has a 50 day moving average price of $87.78 and a 200 day moving average price of $89.57. The company has a market capitalization of $7.05 billion, a price-to-earnings ratio of 40.86 and a beta of 1.13. West Pharmaceutical Services, Inc. has a 52 week low of $70.17 and a 52 week high of $99.91.

West Pharmaceutical Services (NYSE:WST) last announced its quarterly earnings data on Thursday, July 27th. The medical instruments supplier reported $0.66 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.65 by $0.01. West Pharmaceutical Services had a net margin of 11.42% and a return on equity of 14.02%. The business had revenue of $397.60 million for the quarter, compared to analyst estimates of $406.00 million. During the same period last year, the business earned $0.59 EPS. The company’s revenue was up 2.5% on a year-over-year basis. Equities analysts forecast that West Pharmaceutical Services, Inc. will post $2.68 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, November 1st. Stockholders of record on Wednesday, October 18th will be issued a $0.14 dividend. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.59%. This is a positive change from West Pharmaceutical Services’s previous quarterly dividend of $0.13. The ex-dividend date of this dividend is Tuesday, October 17th. West Pharmaceutical Services’s dividend payout ratio (DPR) is presently 22.22%.

ILLEGAL ACTIVITY NOTICE: “West Pharmaceutical Services, Inc. (WST) Shares Sold by Northwestern Mutual Investment Management Company LLC” was originally posted by BBNS and is owned by of BBNS. If you are accessing this piece on another domain, it was copied illegally and republished in violation of United States and international copyright and trademark laws. The legal version of this piece can be accessed at https://baseballnewssource.com/markets/northwestern-mutual-investment-management-company-llc-decreases-position-in-west-pharmaceutical-services-inc-wst/1600224.html.

West Pharmaceutical Services Profile

West Pharmaceutical Services, Inc is a manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The Company’s products include vial containment solutions, prefillable systems, self-injection platforms, cartridge systems and components, reconstitution and transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing and analytical services.

Institutional Ownership by Quarter for West Pharmaceutical Services (NYSE:WST)

Receive News & Ratings for West Pharmaceutical Services Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services Inc. and related companies with our FREE daily email newsletter.

 


Latest News

American League Once Again Dominates National League
American League Once Again Dominates National League
Los Angeles Dodgers Waiting But Magic Number Down to One
Los Angeles Dodgers Waiting But Magic Number Down to One
Young Girl Hit by Foul Ball Rushed to Hospital
Young Girl Hit by Foul Ball Rushed to Hospital
New Home Run Record Reached in Major League Baseball
New Home Run Record Reached in Major League Baseball
Will 2017 MLB Season End with No 20-Game Winner?
Will 2017 MLB Season End with No 20-Game Winner?
Cleveland Indians Winning Streak Snapped at 22
Cleveland Indians Winning Streak Snapped at 22


Leave a Reply

 
© 2006-2017 BBNS.